17α-methyltestosterone (MET) is an aquaculture premix and is only available through Rangen Inc. The primary goal of studies conducted under INAD #8557 is to generate data evaluating the efficacy of MET administered in feed to larval rainbow trout and Atlantic salmon to produce masculinized female fish that produce sperm. The treatment option that is allowed for rainbow trout is a dose of 10.8 mg active drug/kg of fish biomass. MET will be incorporated into feed by Rangen, Inc. at a rate of 3 mg MET/kg feed. MET-medicated feed should be fed to rainbow trout for 60 consecutive days. The treatment option that is allowed for Atlantic salmon is a dose of 6.3 mg active drug/kg of fish biomass. MET will be incorporated into feed by Rangen, Inc. at a rate of 1 mg MET/kg feed. MET-medicated feed should be fed to Atlantic salmon for 105 consecutive days. No retreatment will be allowed. Investigational withdrawal is 120 days. This INAD requires all participants to be approved by the FDA Environmental Team prior to participation – this review will take 100 days. To participate in the INAD Program for MET visit the data collecting site.
Please read the Study Protocol prior to any treatments. It contains the protocol, MSDS, and a copy of the forms to be used as a guide for collecting data that will be entered into the online INAD database. The FDA authorization letter(s) for this INAD is currently only available by emailing Bonnie Johnson . Gonadal Steroids
Rangen Inc.PO Box 706 Buhl , ID 83316 United States
Investigator needs to report general fish behavior and any adverse effects relating to treatment.
Working with others to conserve, protect and enhance fish, wildlife, plants and their habitats for the continuing benefit of the American people.
You are being directed to
Test Steroid We do not guarantee that the websites we link to comply with Section 508 (Accessibility Requirements) of the Rehabilitation Act. Links also do not constitute endorsement, recommendation, or favoring by the U.S. Fish and Wildlife Service.